Doç. Dr. HACI HASAN YETER

Yayın Ağı

Makaleler 56

1. Prevalence of Hypertension and Blood Pressure Control in Familial Mediterranean Fever Patients

KAVGACI G., YETER H. H., ÜZERK KİBAR M., YILDIRIM T., Peynircioglu B. B., YILMAZ Ş. R., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , sa.1, 2025 (SCI-Expanded, Scopus)

2. Association of vascular endothelial growth factor-C, plasma angiotensinogen and left ventricular hypertrophy in patients with hemodialysis.

Yeter H. H., Levent M., Sahiner L., Yildirim T., Yilmaz R.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy , cilt.28, ss.904-911, 2024 (SCI-Expanded, Scopus)

3. Cases report: Unexpected arterial thromboembolic events without cardiac involvement in two AA amyloidosis patients

HABERAL G., YETER H. H.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.27, sa.10, 2024 (SCI-Expanded, Scopus)

4. Effects of incremental peritoneal dialysis with low glucose-degradation product neutral pH solution on clinical outcomes.

Yeter H. H., Altunok M., Cankaya E., Yildirim S., Akturk S., Bakirdogen S., et al.

International urology and nephrology , cilt.56, ss.3123-3132, 2024 (SCI-Expanded, Scopus)

5. Rare case of aspergillosis with solitary renal involvement: micro-fungus ball in graft kidney.

Haberal G., Saglam A., Yildirim T., Yilmaz S. R., Yeter H. H.

CEN case reports , 2024 (ESCI, Scopus)

6. Pretransplant Parathyroidectomy in Patients with Severe Secondary Hyperparathyroidism and Long-Term Effectiveness After Kidney Transplantation.

Akcay O. F., Yeter H. H., Yuksel O., Guz G.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme , cilt.56, sa.7, ss.489-497, 2024 (SCI-Expanded, Scopus)

7. Effects of a medium cut-off dialyzer on inflammation and cardiac and vascular function in hemodialysis patients with heart failure.

Ozarli I., Yeter H. H., Sener Y. Z., Cebrailov C., Yildirim T., Yilmaz R.

Hemodialysis international. International Symposium on Home Hemodialysis , cilt.28, sa.3, ss.326-335, 2024 (SCI-Expanded, Scopus)

8. Risk Factors for Posttransplant Erythrocytosis: Parathyroid Hormone Paradox?

Yeter H. H., Fettahoglu F., Yesiloglu E., Akcay O., Korucu B., Bali M., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , cilt.22, sa.2, ss.103-107, 2024 (SCI-Expanded, Scopus)

9. Effect of medium cut-off membranes on Pentosidine and N-(carboxymethyl) lysine levels in uncontrolled diabetic hemodialysis patients

Koç N. S., YETER H. H., YILDIRIM T., ERDEM Y., Yılmaz R.

Therapeutic Apheresis and Dialysis , 2024 (SCI-Expanded, Scopus)

10. TCF7L2 (rs7903146) But Not CDKAL1 (rs7754840) Gene Polymorphisms Increase the Risk of New-Onset Diabetes After Kidney Transplant.

Helvaci Ö., Korucu B., Yeter H. H., Gönen S., Cavnar Helvaci B., Sanisoğlu Y., et al.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation , cilt.21, sa.11, ss.872-878, 2023 (SCI-Expanded, Scopus)

11. Outcomes of early-start peritoneal dialysis (PD) and the comparison with urgent-start hemodialysis and conventional-start PD

YETER H. H., Izgi A., Yildirim S., Akcay O. F., DERİCİ Ü.

Therapeutic Apheresis and Dialysis , cilt.27, sa.3, ss.480-487, 2023 (SCI-Expanded, Scopus)

12. Impact of medium cut-off membranes on S100A12 and soluble receptor for advanced glycation end products

Korucu B., YETER H. H., GÖNEN S., Derici M. K., Ronco C., DERİCİ Ü.

Seminars in Dialysis , cilt.36, sa.3, ss.193-200, 2023 (SCI-Expanded, Scopus)

13. Comparison of soluble suppression of tumorigenicity 2 and brachial hemodynamic parameters between dialysis modalities in patients with end-stage kidney disease

YETER H. H., Karacalik C., Eraslan E., Durantas H., Akcay O. F., Derici K., et al.

International Urology and Nephrology , cilt.55, sa.5, ss.1335-1342, 2023 (SCI-Expanded, Scopus)

14. Impact of HLA polymorphisms on the susceptibility to SARS-CoV-2 infection and related mortality in patients with renal replacement therapy

Akcay O. F., YETER H. H., ÜNSAL Y., Yasar E., GÖNEN S., DERİCİ Ü.

Human Immunology , cilt.84, sa.4, ss.272-277, 2023 (SCI-Expanded, Scopus)

15. Association of longitudinal high-sensitive C-reactive protein levels with changing membrane characteristics in peritoneal dialysis

Korucu B., DEĞER S. M., YETER H. H., Akcay O. F., Cimen Y., Dogan B., et al.

Artificial Organs , cilt.47, sa.3, ss.547-553, 2023 (SCI-Expanded, Scopus)

16. The Significance of Systemic Immune-Inflammatory Index and Platelet-Neutrophil Ratio on Early Mortality in Septic Shock Patients and their Association with Vitamin D and Parathyroid Hormone Ratio

YETER H. H., TOPELİ İSKİT A.

Acta Medica , cilt.53, sa.4, ss.384-393, 2022 (TRDizin)

17. YouTube as a platform for knowledge and awareness of peritoneal dialysis: A content analysis

YETER H. H., Akcay O. F.

Peritoneal Dialysis International , cilt.42, sa.5, ss.489-496, 2022 (SCI-Expanded, Scopus)

18. THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy

Aktepe O. H., Gundogdu F., Kosemehmetoglu K., Yeter H. H., Aksoy S., Guven D. C., et al.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.191, sa.4, ss.1561-1567, 2022 (SCI-Expanded, Scopus)

19. Predictive value of neutrophil-to-lymphocyte ratio in terms of need for intensive care unit and mortality in maintenance hemodialysis patients with COVID-19

Oguz E. G., YETER H. H., Akcay O. F., Besli S., Selen T., DERİCİ Ü., et al.

Hemodialysis International , cilt.26, sa.3, ss.377-385, 2022 (SCI-Expanded, Scopus)

20. The Effects of CNI and Mtori-Based Regimens on Bone Mineral Density After Renal Transplantation

KORUCU B., YETER H. H., GÜZ G.

Prilozi , cilt.43, sa.1, ss.101-107, 2022 (Hakemli Dergi)

21. Discontinuation of Eculizumab treatment after hematological remission in patients with atypical and drug-induced hemolytic uremic syndrome

YETER H. H., DERİCİ Ü., ARINSOY S. T., ALTOK K., ERTEN Y., GÜZ G.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , cilt.60, sa.1, ss.56-65, 2022 (ESCI, Scopus)

22. Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?

Yasar E., ÖZGER H. S., YETER H. H., Yildirim C., Osmanov Z., ÇETİN T. E., et al.

International Urology and Nephrology , cilt.54, sa.3, ss.627-636, 2022 (SCI-Expanded, Scopus)

23. Factors Affecting Bone Health in Kidney Transplant Recipients: Klotho Gene Single-Nucleotide Polymorphisms and Other Clinical Features

YETER H. H., Helvaci O., Korucu B., GÖNEN S., GÜZ G., DERİCİ Ü.

Experimental and Clinical Transplantation , cilt.20, sa.4, ss.370-379, 2022 (SCI-Expanded, Scopus)

24. The utility of remote patient management in peritoneal dialysis

YETER H. H., Manani S. M., Ronco C.

Clinical Kidney Journal , cilt.14, sa.12, ss.2483-2489, 2021 (SCI-Expanded, Scopus)

25. The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy

AKTEPE O. H., GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇELİKTEN B., Yeter H. H., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.73, sa.10, ss.1957-1963, 2021 (SCI-Expanded, Scopus)

26. Obstetric and long-term graft outcomes in pregnant kidney transplant recipients: A single-center experience

Akcay O. F., YETER H. H., KARÇAALTINCABA D., Bayram M., GÜZ G., ERTEN Y.

Clinical Transplantation , cilt.35, sa.8, 2021 (SCI-Expanded, Scopus)

27. A possible contributor to erythropoiesis-stimulating agents requirement in hemodialysis: Paraoxonase 1 activity

KORUCU B., YETER H. H., BALİ E. B., DERİCİ M. K., GÜZ G.

UNIVERSOS JURÍDICOS , cilt.3, sa.3, ss.116-122, 2021 (Hakemli Dergi)

28. Association between calcitriol and paricalcitol with oxidative stress in patients with hemodialysis

YETER H. H., Korucu B., BALİ E. B., DERİCİ Ü.

International Journal for Vitamin and Nutrition Research , cilt.91, sa.3-4, ss.335-342, 2021 (SCI-Expanded, Scopus)

29. Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy

YETER H. H., IŞIK GÖNÜL İ., Eraslan E., Karacalik C., ÖĞÜT B., GÜZ G.

Clinical and Experimental Nephrology , cilt.25, sa.5, ss.488-500, 2021 (SCI-Expanded, Scopus)

30. Vitamin D receptor polymorphisms and bone health after kidney transplantation

KORUCU B., TÜKÜN F. A., HELVACI Ö., YETER H. H., GÖNEN S., GÜZ G., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.2, ss.802-812, 2021 (SCI-Expanded, Scopus, TRDizin)

31. Effect of the tunneled-cuffed central venous catheters on oxidative stress indices and inflammation in chronic hemodialysis patients

KORUCU B., YETER H. H., BALİ E. B., DERİCİ M. K.

THE EUROPEAN RESEARCH JOURNAL , cilt.7, sa.2, ss.127-135, 2021 (TRDizin)

32. The reliability and success of peritoneal dialysis during the COVID-19 pandemic

YETER H. H., Gok Oguz E., Akcay O. F., Karaer R., Yasar E., Duranay M., et al.

Seminars in Dialysis , cilt.34, sa.2, ss.147-156, 2021 (SCI-Expanded, Scopus)

33. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma

AKTEPE O. H., GÜNER G., GÜVEN D. C., TABAN H., YILDIRIM H. Ç., ŞAHİN T. K., et al.

TURKISH JOURNAL OF UROLOGY , cilt.47, sa.2, ss.113-119, 2021 (ESCI, Scopus, TRDizin)

34. Combining clinical features and MEST-C score in IgA nephropathy may be a better determinant of kidney survival

YETER H. H., IŞIK GÖNÜL İ., GÜZ G. T., HELVACI Ö., KORUCU B., AKÇAY Ö. F., et al.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , cilt.58, sa.4, ss.209-218, 2020 (ESCI, Scopus)

35. Effect of remote patient management in peritoneal dialysis on haemodynamic and volume control

YETER H. H., Karacalik C., Eraslan E., Akcay O. F., DERİCİ Ü., Ronco C.

Nephrology , cilt.25, sa.11, ss.856-864, 2020 (SCI-Expanded, Scopus)

36. Changing Aspect in Adult Kidney Biopsies: Ten Years Single Center Experience

YETER H. H., GECEGELEN E., BAŞTUĞ V., KORUCU B., FETTAHOĞLU F. C., IŞIK GÖNÜL İ., et al.

GAZI MEDICAL JOURNAL , cilt.31, sa.4, ss.563-568, 2020 (ESCI, Scopus)

37. Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience

AKÇAY Ö. F., YETER H. H., BÜYÜKAŞIK Y.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , cilt.58, sa.3, ss.138-145, 2020 (ESCI, Scopus)

38. Effects of medium cut-off dialysis membranes on inflammation and oxidative stress in patients on maintenance hemodialysis

YETER H. H., Korucu B., Akcay O. F., Derici K., DERİCİ Ü., Arinsoy T.

International Urology and Nephrology , cilt.52, sa.9, ss.1779-1789, 2020 (SCI-Expanded, Scopus)

39. Can Helicobacter pylori Colonization Affect the Phosphate Binder Pill Burden in Dialysis Patients?

Korucu B., HELVACI Ö., Sadioglu R., Ozbas B., YETER H. H., DERİCİ Ü.

Therapeutic Apheresis and Dialysis , cilt.24, sa.4, ss.380-386, 2020 (SCI-Expanded, Scopus)

40. Late acute cellular rejection after anakinra treatment in a kidney transplant patient, is it a coincidence?

YETER H. H., Yetkin N., Akcay O. F., DERİCİ Ü., Arinsoy T.

Iranian Journal of Kidney Diseases , cilt.14, sa.4, ss.318-320, 2020 (SCI-Expanded, Scopus)

41. Relationship Among Denture Status, Remaining Teeth Number, and Malnutrition in Patients With Chronic Kidney Disease

Sevmez H., BANKOĞLU GÜNGÖR M., YETER H. H., ERTEN Y., Elbeg Ş., YILMAZ H.

Therapeutic Apheresis and Dialysis , cilt.24, sa.3, ss.290-299, 2020 (SCI-Expanded, Scopus)

42. Automated Remote Monitoring for Peritoneal Dialysis and Its Impact on Blood Pressure

YETER H. H., Akcay O. F., Ronco C., DERİCİ Ü.

CardioRenal Medicine , cilt.10, sa.3, ss.198-208, 2020 (SCI-Expanded, Scopus)

43. Ultrastructural evaluation of urine alkalinization versus hydration on colistin-induced nephrotoxicity

Korucu B., Unal I., Pekcan M., İNKAYA A. Ç., Yeter H. H., ÇETİNKAYA M. A., et al.

Human and Experimental Toxicology , cilt.38, sa.12, ss.1366-1377, 2019 (SCI-Expanded, Scopus)

44. Could drug burden be associated with severe periodontitis in patients receiving haemodialysis?

YETER H. H., ERTEN Y., İŞLER S. Ç., Soysal F., Elbeg S., ÜNSAL F. B.

Journal of Renal Care , cilt.45, sa.4, ss.239-247, 2019 (SCI-Expanded, SSCI, Scopus)

45. Oral Candida Colonization as a Risk Factor for Chronic Inflammation and Atherosclerosis in Hemodialysis Patients

YETER H. H., ERTEN Y., Sevmez H., Korucu B., KALKANCI A., Elbeg S., et al.

Therapeutic Apheresis and Dialysis , cilt.23, sa.6, ss.542-549, 2019 (SCI-Expanded, Scopus)

46. Low Copeptin Levels in Patients With Intradialytic Hypotension

Korucu B., HELVACI Ö., Ozbas B., Yeter H. H., YÜCE D., ELBEG Ş., et al.

THERAPEUTIC APHERESIS AND DIALYSIS , cilt.23, sa.5, ss.460-466, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience

YETER H. H., Sütiçen E., KORUCU B., HELVACI Ö., ÖZBAŞ B., IŞIK GÖNÜL İ., et al.

PRILOZI , cilt.40, sa.2, ss.15-23, 2019 (Hakemli Dergi)

48. Hypothalamic Energy Regulatory Peptides in Chronic Kidney Disease

Korucu B., Erten Y. T., YETER H. H., EROĞLU ALTINOVA A., Pasaoglu O. T., PAŞAOĞLU H., et al.

Therapeutic Apheresis and Dialysis , cilt.23, sa.5, ss.437-443, 2019 (SCI-Expanded, Scopus)

49. Prognostic factors in glomerular diseases with crescents

YETER H. H., IŞIK GÖNÜL İ., DEMİREL E., KORUCU B., DERİCİ Ü.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , cilt.57, sa.3, ss.254-261, 2019 (Scopus)

50. Mild to moderate proteinuria is a heralding sign for acute kidney injury and mortality for intensive care unit patients

Yeter H. H., Yıldırım T., Eyüpoğlu D., Paşayev T., Aslan A., Çetik S., et al.

Turkish Journal of Medical Sciences , cilt.49, sa.2, ss.543-550, 2019 (SCI-Expanded, Scopus, TRDizin)

51. Gorham-Stout disease or new entity on the basis of vasculopathy

YETER H. H.

ALEXANDRIA JOURNAL OF MEDICINE , cilt.53, sa.2, ss.193-196, 2017 (ESCI)

52. Prognostic factors and treatment of patients with advanced synovial sarcoma: A single-center experience

Ates O., Aksoy S., Yeter H. H., Sunar V., Kertmen N., Dizdar O., et al.

INDIAN JOURNAL OF CANCER , cilt.54, sa.1, ss.321-325, 2017 (SCI-Expanded, Scopus)

53. Urinary Tract Infection Caused by Raoutella Ornithinolytica in a Patient With Bladder Cancer

YETER H. H., AKTEPE O. H.

Türkiye Klinikleri Journal of Medical Research , cilt.24, sa.3, ss.216-218, 2016 (TRDizin)

54. Tumor Lysis like Syndrome Associated with Cytomegalovirus: A Case Report

YETER H. H., HOUSSEIN M., HALİL M. G.

Journal of Cytology Histology , cilt.6, sa.05, 2015 (Hakemli Dergi)

55. endocrine myopathies

YETER H. H.

endocrinology and metabolic syndrome , cilt.4, ss.1-6, 2015 (Hakemli Dergi)

56. Endocrine Myopathies: Clinical Review

YETER H. H.

Endocrinology Metabolic Syndrome , cilt.4, sa.2, ss.1000178, 2015 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 50

1. Utility of cinacalcet treatment in kidney transplant recipients with persistent hyperparathyroidism

Akcay O. F., YETER H. H., GÜZ G.

61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)

2. Inadequate diagnostic investigations and low treatment rates in CKD anemia: an inertia that can only change with long-term follow-up

Kurak C. d. K., Karlik S., HAYRAN K. M., HABERAL G., ERDUT A., YETER H. H., et al.

61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)

3. IMPACT OF HYPERTENSION ON OUTCOMES IN PATIENTS WITH MEMBRANOUS NEPHROPATHY

ŞENER Y. Z., Jabrayilov J., ÇELEBİ G., HABERAL G., ERDUT A., Ayhan A. S., et al.

33rd European Meeting on Hypertension and Cardiovascular Renal Protection (ESH), Berlin, Almanya, 31 Mayıs - 03 Haziran 2024, (Özet Bildiri)

4. Membranous nephropathy has higher all-cause mortality rate in comparison to focal segmental glomerulosclerosis and IgA nephropathy: a long-term study

Ziya Y. S., Jabrayi'lov J., ÇELEBİ G., HABERAL G., ERDUT A., YETER H. H., et al.

61st Congress of European-Renal-Association (ERA), Stockholm, İsveç, 23 - 26 Mayıs 2024, (Özet Bildiri)

5. BÖBREK NAKLI SONRASI PATOLOJIK KEMIK KIRIKLARINA NEDEN OLABILECEK RISK FAKTÖRLERININ INCELENMESI

AKÇAY Ö. F., YETER H. H., HELVACI Ö., DERİCİ Ü., ERTEN Y., GÜZ G.

7. HİPERTANSİYON NEFROLOJİ DİYALİZ VE TRANSPLANTASYON KONGRESİ, Girne, Kıbrıs (Kktc), 1 - 04 Haziran 2023, (Özet Bildiri)

6. ASSOCIATION OF SYSTEMIC INFLAMMATION WITH CHANGING PERITONEAL MEMBRANE CHARACTERISTICS

KORUCU B., YETER H. H., AKÇAY Ö. F., GÜZ G.

59TH ERA CONGRESS, Paris, Fransa, 19 - 22 Mayıs 2022, (Özet Bildiri)

7. Diyabetik Nefropatili Hastalarda COVİD-19 Enfeksiyonunun Nefropati Progresyonuna Etkisi

TİMÜÇİN M., YETER H. H.

24.ULUSAL HİPERTANSİYON VE BÖBREK HASTALIKLARI KONGRESİ, DALAMAN, Türkiye, 11 - 15 Mayıs 2022, (Özet Bildiri)

8. Böbrek nakilli hastalarda valvuler kalsifikasyon gelişimi için risk faktörleri ve uzun dönemli sonlanımlara etkileri

AKÇAY Ö. F., YETER H. H., YILDIRIM S., YAŞAR E., GÜZ G.

5. HİPERTANSİYON NEFROLOJİ DİYALİZ VE TRANSPLANTASYON KONGRESİ, Adana, Türkiye, 11 - 14 Kasım 2021, (Özet Bildiri)

9. BÖBREK NAKLİ SONRASI YENİ BAŞLANGIÇLI DM İLE NAKİL ÖNCESİ DÖNEMDE DM VARLIĞININ NAKİL SONRASI SONLANIMLARA ETKİSİ

AKÇAY Ö. F., YETER H. H., GÜZ G.

38. ULUSAL NEFROLOJİ KONGRESİ, Girne, Kıbrıs (Kktc), 13 - 17 Ekim 2021, (Özet Bildiri)

10. NÖTROFİL/LENFOSİT ORANININ COVID-19’LU HEMODİYALİZ HASTALARINDA YOĞUN BAKIM YATIŞI VE MORTALİTE İLE İLİŞKİSİ

AKÇAY Ö. F., YETER H. H., DERİCİ Ü.

10. ULUSLARARASI KATILIMLI GÜNCEL BÖBREK HASTALIKLARI HIPERTANSIYON VE TRANSPLANTASYON KONGRESI, SAPANCA, Türkiye, 15 - 19 Eylül 2021, (Özet Bildiri)

11. PERITONITIS RISK OF PD MODALITIES AND TECHNICAL SURVIVAL ACCORDING TO BASELINE PERITONEAL TRANSPORT STATUS

YETER H. H., AKÇAY Ö. F., GÜZ G.

58TH ERA-EDTA CONGRESS, ONLINE, 5 - 06 Haziran 2021, (Özet Bildiri)

12. CNI AND MTORI-BASED REGIMENS ON FIVE-YEAR COURSE OF BONE MINERAL DENSITY SCORES AFTER RENAL TRANSPLANTATION

KORUCU B., YETER H. H., GÜZ G.

58TH ERA-EDTA CONGRESS, ONLINE, 5 - 06 Haziran 2021, (Özet Bildiri)

13. MEMBRANÖZ NEFROPATI OLGULARINDA PLA2R VE THSD7A EKSPRESYONU

ÖĞÜT B., YETER H. H., IŞIK GÖNÜL İ., GÜZ G.

30.ULUSAL PATOLOJİ KONGRESİ, Türkiye, 20 - 23 Mayıs 2021, (Özet Bildiri)

14. NAKİL ÖNCESİ DİYALİZ YÖNTEMLERİNİN POST-TRANSPLANTASYON SONLANIMLARA ETKİSİ

AKÇAY Ö. F., YETER H. H., DERİCİ Ü.

19. NEFROLOJİ KIŞ OKULU, ONLINE, Türkiye, 20 - 23 Mayıs 2021, (Özet Bildiri)

15. Böbrek Nakli Sonrası CMV Enfeksiyonu: Her CMV Enfeksiyon Epizodu Böbrek Sağ Kalımında Benzer Etkiye Sahip mi?

YETER H. H., AKÇAY Ö. F., DERİCİ Ü.

17. ULUDAĞ İÇ HASTALIKLARI ULUSAL KIŞ KONGRESİ, ONLINE, Türkiye, 5 - 07 Mart 2021, (Özet Bildiri)

16. DİYALİZ HASTASINDA SERUM MAGNEZYUMU: HANGİ HASTALARDA TAKİP EDELİM?

KORUCU B., YETER H. H., DERİCİ Ü.

4. HİPERTANSİYON NEFROLOJİ DİYALİZ VE TRANSPLANTASYON KONGRESİ, ONLINE, Türkiye, 18 - 20 Aralık 2020, (Özet Bildiri)

17. BÜYÜK DAMAR VE KÜÇÜK DAMAR VASKÜLITI OLAN HASTALARDA ARTERIYEL SERTLIĞIN DEĞERLENDIRILMESI

DURANTAŞ H., YETER H. H., KARADENİZ H., TUFAN A., DERİCİ Ü.

22. ULUSAL HİPERTANSİYON VE BÖBREK HASTALIKLARI KONGRESİ, ONLINE, Türkiye, 5 - 08 Kasım 2020, (Özet Bildiri)

18. MEDİUM CUT-OFF MEMBRANIN RENAL ANEMİ VE KEMİK MİNERAL METABOLİZMASI ÜZERİNE ETKİLERİ

AKÇAY Ö. F., YETER H. H., ARINSOY S. T.

37. ULUSAL NEFROLOJİ KONGRESİ, ONLINE, Türkiye, 15 - 18 Ekim 2020, (Özet Bildiri)

19. LONG TERM RENAL FUNCTIONS IN LIVING KIDNEY DONORS AND ITS RELATIONSHIP WITH TRANSFORMING GROWTH FACTOR ßETA-1GENE POLYMORPISMS

TÜZÜN B. K., HELVACI Ö., YETER H. H., ÖZBAŞ B., KORUCU B., GÖNEN S., et al.

57th ERA-EDTA Congress, ONLINE, 6 - 09 Haziran 2020, (Özet Bildiri)

20. HEMODİYALİZ HASTALARINDA VASKÜLER GİRİŞ YOLU İLE TİYOL/DİSÜLFİD HOMEOSTAZİSİ İLİŞKİSİ

KORUCU B., YETER H. H., BALİ E. B., DERİCİ Ü.

36. ULUSAL NEFROLOJİ KONGRESİ, Antalya, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)

21. TÜRKİYE’DE IGA NEFROPATİLİ HASTALARIN EPİDEMİYOLOJİK VE KLİNİK ÖZELLİKLERİ

EREN N., Gursu M., CEBECİ E., TÜRKMEN A., YETER H. H., SEYAHİ N., et al.

36.Ulusal Nefroloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)

22. BÖBREK NAKİLLİ HASTALARDA SOL VENTRİKÜL HİPERTROFİSİ GELİŞİMİ İÇİN RİSK FAKTÖRLERİ: 5 YILLIK TEK MERKEZ DENEYİMİ

YETER H. H., BOZ O., BALİ M.

21. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 9 - 13 Ekim 2019, (Özet Bildiri)

23. FACTORS EFFECTING LEFT VENTRICULAR STRUCTURE IN PATIENTS WITH KIDNEY TRANSPLANTATION

YETER H. H., KORUCU B., DERİCİ Ü.

19TH CONGRESS OF THE EUROPEAN SOCIETY FOR ORGAN TRANSPLANTATION, COPENHAGEN, Danimarka, 15 - 18 Eylül 2019, (Özet Bildiri)

24. aHÜS ve TANIDA GENETİK TESTLER

YETER H. H.

3. ANKARA HİPERTANSİYON NEFROLOJİ DİYALİZ VE TRANSPLANTASYON GÜNLERİ, Bolu, Türkiye, 20 - 23 Haziran 2019, (Özet Bildiri)

25. KRONİK HEMODİYALİZ HASTALARINDA ULTRAFİLTRASYON MİKTARI İLE İSKEMİ MODİFİYE ALBUMİN DÜZEYİ İLİŞKİSİ

KORUCU B., YETER H. H., BALİ E. B., BALİ M.

3. ANKARA HİPERTANSİYON NEFROLOJİ DİYALİZ VE TRANSPLANTASYON GÜNLERİ, Bolu, Türkiye, 20 - 23 Haziran 2019, (Özet Bildiri)

26. HELICOBACTER PYLORI COLONISATION INCREASES PHOSPHATE BINDER PILL BURDEN IN DIALYSIS PATIENTS

KORUCU B., HELVACI Ö., EREN SADİOĞLU R., ÖZBAŞ B., YETER H. H., DERİCİ Ü.

56TH ERA-EDTA CONGRESS, Budapest, Macaristan, 13 - 16 Haziran 2019, (Özet Bildiri)